| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | Johannes Jacob Kastelein | Chief Scientific Officer | Aug 21, 2025 | Sale | $24.29 | 50,000 | 1,214,500 | 119,302 | Aug 25, 2025, 05:04 PM | |
| NAMS | NewAmsterdam Pharma Co N.V. | Johannes Jacob Kastelein | Chief Scientific Officer | Aug 22, 2025 | Sale | $25.14 | 50,000 | 1,257,140 | 76,960 | Aug 25, 2025, 05:04 PM | |
| NAMS | NewAmsterdam Pharma Co N.V. | Johannes Jacob Kastelein | Chief Scientific Officer | Mar 26, 2025 | Option/RSU Exercise | - | 45,481 | - | 79,481 | Mar 28, 2025, 05:20 PM | |
| NAMS | NewAmsterdam Pharma Co N.V. | Johannes Jacob Kastelein | Chief Scientific Officer | Mar 24, 2025 | Option/RSU Exercise | - | 150,000 | - | 150,000 | Mar 26, 2025, 04:27 PM | |
| NAMS | NewAmsterdam Pharma Co N.V. | Johannes Jacob Kastelein | Chief Scientific Officer | Mar 26, 2024 | Sale | $21.50 | 190,476 | 4,095,234 | 0 | Mar 27, 2024, 04:30 PM | |
| NAMS | NewAmsterdam Pharma Co N.V. | Johannes Jacob Kastelein | Chief Scientific Officer | Mar 26, 2024 | Tax Payment (Shares) | $22.72 | 11,197 | 254,396 | 190,476 | Mar 27, 2024, 04:30 PM | |
| NAMS | NewAmsterdam Pharma Co N.V. | Johannes Jacob Kastelein | Chief Scientific Officer | Mar 26, 2024 | Option/RSU Exercise | - | 201,673 | - | 201,673 | Mar 27, 2024, 04:30 PM |